GLP-1 and Gastroparesis: Understanding the Risk and What You Need to Know

If you've been reading about GLP-1 medications like semaglutide or tirzepatide, you may have come across alarming headlines about gastroparesis—sometimes called "stomach paralysis." It's understandably concerning, especially when you're trying to make an informed decision about your health. Let's walk through what we actually know about GLP-1s and gastroparesis risk, what the science tells us, and how to approach these medications safely.

What Is Gastroparesis?

Gastroparesis is a condition where your stomach takes too long to empty its contents into the small intestine. Normally, strong muscular contractions push food through your digestive tract. With gastroparesis, these contractions slow down or don't work properly.

Symptoms can include persistent nausea, vomiting (especially of undigested food), feeling full quickly when eating, bloating, and abdominal pain. In severe cases, it can lead to unpredictable blood sugar levels, nutritional deficiencies, and significantly impact quality of life.

The condition can be caused by diabetes, certain medications, surgery, or neurological conditions. Sometimes, doctors can't identify a clear cause.

How GLP-1 Medications Affect Stomach Emptying

Here's an important distinction: GLP-1 medications are designed to slow stomach emptying. This is actually one of the ways they work to help with weight loss and blood sugar control.

When your stomach empties more slowly, you feel fuller longer. This reduces appetite and helps you eat less. For people with diabetes, slower stomach emptying also means glucose enters the bloodstream more gradually, preventing blood sugar spikes.

This intentional slowing of digestion is called delayed gastric emptying, and it's a normal, expected effect of GLP-1 therapy. It's not the same as gastroparesis, though the symptoms can sometimes overlap.

The Difference Between Delayed Gastric Emptying and Gastroparesis

This is the crucial point many headlines miss: temporary, medication-induced delayed gastric emptying is different from gastroparesis.

With GLP-1 medications, stomach emptying typically returns to normal after you stop taking the drug. True gastroparesis is a chronic condition where stomach emptying remains impaired even without medication.

Think of it this way: GLP-1s are like gently tapping the brakes on your digestion. Gastroparesis is like having broken brakes that won't release even when you want them to.

What Does the Research Actually Show?

The connection between GLP-1 medications and gastroparesis has been studied, and the picture is more nuanced than alarming headlines suggest.

Large studies of semaglutide and tirzepatide have not shown a significant increase in gastroparesis cases compared to placebo groups. Most participants experience mild, manageable digestive side effects that improve over time.

A 2023 study that made waves in the media did find a potential association between GLP-1 use and gastroparesis, but it had significant limitations. It looked at medical records retrospectively and couldn't prove cause and effect. Many patients in the study had diabetes, which itself is a leading cause of gastroparesis.

The FDA continues to monitor these medications closely, and gastroparesis is not currently listed as a recognized side effect of GLP-1 medications, though gastrointestinal effects are well-documented.

Who Might Be at Higher Risk?

While true gastroparesis appears to be rare with GLP-1 therapy, certain people may be more likely to experience significant digestive side effects:

• People with pre-existing digestive disorders or motility issues
• Those with long-standing diabetes that may have already affected nerve function
• Individuals who increase their dose too quickly
• People taking multiple medications that affect digestion
• Those with a history of gastrointestinal surgery

If you fall into any of these categories, it doesn't mean you can't use GLP-1 medications—it just means you and your doctor should monitor your symptoms more carefully.

Gender Considerations

Women tend to report gastrointestinal side effects from GLP-1 medications slightly more frequently than men in clinical trials. This may be related to baseline differences in stomach emptying rates, as women naturally have slower gastric emptying than men. Hormonal fluctuations during the menstrual cycle can also affect digestive function, potentially making some women more sensitive to these effects. If you're a woman experiencing significant nausea or digestive issues on GLP-1 therapy, know that you're not alone, and there are strategies to help manage these symptoms.

Warning Signs to Watch For

Most digestive side effects from GLP-1 medications are mild and improve within the first few weeks. However, you should contact your healthcare provider if you experience:

• Severe or persistent nausea and vomiting that prevents you from keeping down food or liquids
• Vomiting undigested food many hours after eating
• Severe abdominal pain or bloating
• Inability to complete your meals or dramatic reduction in food intake
• Signs of dehydration such as dizziness, dark urine, or extreme thirst
• Unintentional weight loss beyond what's expected

These symptoms warrant evaluation, though they don't automatically mean you have gastroparesis.

How to Minimize Digestive Side Effects

Most people can significantly reduce digestive discomfort on GLP-1 medications with a few practical strategies:

• Start low and go slow with dosing—follow your doctor's titration schedule
• Eat smaller, more frequent meals rather than large ones
• Choose foods lower in fat, which empties from the stomach more quickly
• Avoid lying down immediately after eating
• Stay well-hydrated throughout the day
• Limit high-fiber foods if you're experiencing significant symptoms
• Give your body time to adjust—side effects often improve after several weeks

These adjustments can make a meaningful difference in your comfort while your body adapts to the medication.

When to Continue and When to Stop

Mild nausea, occasional bloating, and feeling full more quickly are common and generally manageable. These side effects alone aren't usually a reason to discontinue treatment if the medication is helping you reach your health goals.

However, if digestive symptoms are severe, persistent, or significantly affecting your quality of life and nutrition, talk with your doctor about adjusting your dose or considering whether GLP-1 therapy is right for you.

The goal is always to find a balance where the benefits outweigh any discomfort.

From the Ozari Care Team

If you're experiencing persistent nausea or digestive discomfort on GLP-1 therapy, try eating your largest meal earlier in the day when stomach emptying tends to be faster, and consider keeping a food diary to identify which foods trigger symptoms. Most importantly, don't suffer in silence—reach out to your care team so we can adjust your treatment plan and ensure you're getting the full benefits of therapy while minimizing side effects.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 28, 2026